Tempest Therapeutics Inc (NASDAQ: TPST) on Friday, plunged -8.08% from the previous trading day, before settling in for the closing price of $0.84. Within the past 52 weeks, TPST’s price has moved between $0.70 and $6.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 17.17%. With a float of $39.62 million, this company’s outstanding shares have now reached $43.97 million.
The firm has a total of 25 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is -8609.67%.
Tempest Therapeutics Inc (TPST) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tempest Therapeutics Inc is 9.21%, while institutional ownership is 6.51%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.
Tempest Therapeutics Inc (TPST) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.00% during the next five years compared to 50.16% growth over the previous five years of trading.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Tempest Therapeutics Inc (TPST) is currently performing well based on its current performance indicators. A quick ratio of 2.21 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.64 in one year’s time.
Technical Analysis of Tempest Therapeutics Inc (TPST)
Analysing the last 5-days average volume posted by the [Tempest Therapeutics Inc, TPST], we can find that recorded value of 0.41 million was lower than the volume posted last year of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 24.67%. Additionally, its Average True Range was 0.05.
During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 15.93%, which indicates a significant increase from 4.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.69% in the past 14 days, which was lower than the 63.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8648, while its 200-day Moving Average is $1.2428. Now, the first resistance to watch is $0.8094. This is followed by the second major resistance level at $0.8467. The third major resistance level sits at $0.8664. If the price goes on to break the first support level at $0.7524, it is likely to go to the next support level at $0.7327. Should the price break the second support level, the third support level stands at $0.6954.
Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats
Market capitalization of the company is 35.12 million based on 43,642K outstanding shares. Right now, sales total 0 K and income totals -29,490 K. The company made 0 K in profit during its latest quarter, and -10,560 K in sales during its previous quarter.
